Albendazole updated on 01-29-2025

Intrauterine deaths (as a whole or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17528
R73758		 Celik, 2018 Spontaneous or therapeutic abortus 1st trimester retrospective cohort unexposed, sick Adjustment: No 11.00 [0.16;780.07] C 1/1   2/18 3 1
ref
Total 1 studies 11.00 [0.16;780.07] 3 1
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Celik, 2018Celik, 2018 11.00[0.16; 780.07]310%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: criticalROB mesure: criticalROB reporting: moderate0.950.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 11.00[0.16; 780.07]31 -NACelik, 2018 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 11.00[0.16; 780.07]31 -NACelik, 2018 1 Tags Adjustment   - No  - No 11.00[0.16; 780.07]31 -NACelik, 2018 1 All studiesAll studies 11.00[0.16; 780.07]31 -NACelik, 2018 10.550.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls Out of scale11.00[0.16; 780.07]31 -NACelik, 2018 10.510.01.0